Article info
PDFArrhythmias and sudden death
Original research article
Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy
- Correspondence to Dr Tarekegn Geberhiwot, Endocrinology, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK; tarekegn.geberhiwot{at}uhb.nhs.uk
Citation
Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy
Publication history
- Received April 11, 2019
- Revised June 25, 2019
- Accepted July 3, 2019
- First published August 24, 2019.
Online issue publication
November 13, 2019
Article Versions
- Previous version (24 August 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.